International Stem Cell (ISCO) Assets (2010 - 2026)

International Stem Cell (ISCO) has reported Assets for 17 consecutive years, with $5.1 million the latest figure, recorded in Q2 2026.

• On a quarterly basis, Assets fell 8.85% year-over-year to $5.1 million in Q2 2026; TTM through Jun 2026 was $5.1 million, a 8.85% decrease from a year earlier, with the FY2025 full-year figure at $4.8 million, down 6.84% from the prior year.
• Assets was $5.1 million for Q2 2026 at International Stem Cell, up from $4.8 million in the prior quarter.
• Over five years, Assets peaked at $5.8 million in Q2 2023 and troughed at $4.8 million in Q4 2025.
• A 5-year average of $5.3 million and a median of $5.4 million in 2024 frame the typical range for Assets.
• Across the five-year window, Assets advanced 11.88% in 2023 and slipped 8.85% in 2026, its largest moves.
• Over 5 years, Assets stood at $5.1 million in 2022, then grew by 4.97% to $5.4 million in 2023, then declined by 4.03% to $5.2 million in 2024, then declined by 6.84% to $4.8 million in 2025, then rose by 4.92% to $5.1 million in 2026.
• The last three Assets figures came in at $5.1 million (Q2 2026), $4.8 million (Q4 2025), and $5.3 million (Q3 2025), per Business Quant data.